Zhiyong Liu

ORCID: 0000-0002-5392-9230 · 17 papers in corpus
case-report 2026
BMC women's health ·doi:10.1186/s12905-026-04415-0

BACKGROUND: Synchronous multiple primary malignancies (SMPMs) involving the uterus and ovary pose significant diagnostic challenges, particularly in distinguishing independent primary tumors from metastatic disease when tumors exhibit overl…

review 2026
International journal of molecular medicine ·doi:10.3892/ijmm.2026.5778

Adenomyosis (AM), an estrogen‑dependent chronic inflammatory disease with a rising incidence, has emerged as a major cause of infertility and reduced clinical pregnancy rates in reproductive‑aged women, severely impairing reproductive healt…

2025
·doi:10.2139/ssrn.5517124
diagnostic-accuracy 2024
BMC pediatrics ·doi:10.1186/s12887-024-04704-3

BACKGROUND: Neonatal respiratory distress syndrome (NRDS) is a prevalent cause of respiratory failure and death among newborns, and prompt diagnosis is imperative. Historically, diagnosis of NRDS relied mostly on typical clinical manifestat…

lab-animal 2024
Phytomedicine : international journal of phytotherapy and phytopharmacology ·doi:10.1016/j.phymed.2024.155461

BACKGROUND: The active ingredients of the Chinese medical herb Paris polyphylla, P. polyphylla ethanol extract (PPE) and polyphyllin I (PPI), potentially inhibit epithelial-mesenchymal transition (EMT) in tumors. However, the roles of these…

lab-animal 2023
Tissue & cell ·doi:10.1016/j.tice.2023.102284

Because adenomyosis (AM) ectopic primary cells are hard to come by, have a short lifespan, and the characteristics that alter over time, their utility in AM research is constrained. This study aimed to establish a line of immortalized human…

other 2023
Journal of inflammation research ·doi:10.2147/jir.s402734

PURPOSE: Adenomyosis (AM) is a common benign uterine disorder that has deleterious effects on women's health. However, the pathogenesis of AM is not clearly understood. We aimed to investigate the pathophysiological changes and molecular me…

lab-animal 2022
Evidence-based complementary and alternative medicine : eCAM ·doi:10.1155/2022/6350257

BACKGROUND: The effect of GuizhiFuling Wan (GFW) on adenomyosis (AM) is definite. This study aimed to explore the mechanism and key therapeutic targets of GFW in treating AM through network pharmacology combined with molecular docking and e…

lab-animal 2022
Evidence-based complementary and alternative medicine : eCAM ·doi:10.1155/2022/2624434

OBJECTIVE: To explore the molecular mechanism of the Cinnamomi ramulus and Paris polyphylla Sm. (C-P) drug pair in the treatment of adenomyosis (AM) based on network pharmacology and animal experiments. METHODS: Via a network pharmacology …

2021
·doi:10.6084/m9.figshare.14183837

Additional file 1: Figure S1. HE staining and QC. (A) Samples from the AM_CTRL, AM_EM and AM_EC groups were HE stained, and the black arrow shows the gland invading the muscular layer. (B) X axis represents the number of UMI in each cell, a…

2021
·doi:10.6084/m9.figshare.14183840

Additional file 2: Table S1. Doublet score and predicted doublets.

2021
·doi:10.6084/m9.figshare.14183843

Additional file 3: Table S2. DEGs of AM_EC vs. AM_EM (all cell types).

2021
·doi:10.6084/m9.figshare.14183846

Additional file 4: Table S3. Coexisting genes in Venn.

2021
·doi:10.6084/m9.figshare.14183849

Additional file 5: Table S4. DEGs of AM_EC vs. AM_EM (epithelial cells).

2021
·doi:10.6084/m9.figshare.14183852

Additional file 6: Table S5. Clinical characteristics of AM patients and hysteromyoma samples used in this study.

other 2021
Cell & bioscience ·doi:10.1186/s13578-021-00562-z

BACKGROUND: Adenomyosis (AM) is a common benign chronic gynaecological disorder; however, the precise pathogenesis of adenomyosis is still poorly understood. Single-cell RNA sequencing (scRNA-seq) can uncover rare subpopulations, explore ge…

2020
·doi:10.21203/rs.3.rs-127243/v1

Abstract Background: Adenomyosis (AM) is a common benign chronic gynaecological disorder; however, the precise pathogenesis of adenomyosis is still poorly understood. Single-cell RNA sequencing (scRNA-seq) can uncover rare subpopulations, …